About

 

Ingmar Gorman, Ph.D., is a clinical psychologist who specializes in assisting populations who have had experiences with psychedelics and other psychoactive compounds. He is the Director of the Psychedelic Education and Continuing Care Program, where he leads groups, trainings, and works with individual clients. Dr. Gorman is also site co-principal Investigator and therapist on a Phase 3 clinical trial studying the potential psychotherapeutic utility of MDMA for post-traumatic stress disorder. He is a NIH funded fellow at New York University and a board member of Horizons Media, Inc., a not for-profit educational charity and organizer of the Horizons Conference: Perspectives on Psychedelics. Email: ingmar@psychedelicprogram.com

 
2_avatar_1.png

Andrew Tatarsky, Ph.D., is a leader in the field of harm reduction psychotherapy. The founder and  director of The Center for Optimal Living in New York City, where treatment and professional training is based on Integrative Harm Reduction Therapy (IHRP). He has specialized in the field of substance use treatment for 35 years working as a counselor, psychologist, program director, trainer, advocate and author. He has devoted his career to developing a comprehensive understanding of the broad spectrum of substance use problems and an integrative harm reduction psychotherapy approach to treating this spectrum.

 

Jen Talley, Ph.D. is a clinical psychologist who specializes in the treatment of trauma and co-occurring substance misuse.  She is the Assistant Director of The Center for Optimal Living.  Working from an integrative harm reduction framework, Dr. Talley’s approach is interactive and focuses on the development of practical skills to manage intense emotions, reduce self-judgment, and promote self-compassion. Mindfulness skills are integrated into an active exploration of the interrelationship between thoughts, feelings, physical sensations, and behaviors, along with their contribution to substance misuse and relationship issues. Dr. Talley is also the Assistant Director of the Concentration in Mental Health and Substance Abuse Counseling at the New School for Social Research where she participates in the training and supervision of graduate students in psychology.

 
3_avatar_1.png
25_avatar_1-ncvgaq46zgbyus5p9n643526svqylvpryp8mg9105c.png

Dr. Elizabeth Nielson is a clinical psychologist with a holistic, compassionate, and integrative approach to psychotherapy. She specializes in treating addictive and mood disorders with a blend of of mindfulness-based interventions, dialectical behavior therapy, psychodynamic therapy, community reinforcement and family training (CRAFT), and principles of psychedelic-assisted therapy. Dr. Nielson’s work is guided by the idea that each individual has within them the capacity for growth and change, and sets out to support the natural healing process by building awareness, autonomy, and self-compassion. Dr. Nielson is part of the Experimental Therapeutics Research Laboratory at NYU Langone School of Medicine where she is a therapist on the psilocybin-assisted treatment for alcohol dependence trial and on the MDMA-assisted psychotherapy for PTSD clinical trials. Email Elizabeth:  enielson@cfol.org Phone: 212-213-8905 x107


 

Advisory Board